Clinical Trial Update: Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating radiation therapy with gadolinium texaphyrin for supratentorial glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Gadolinium texaphyrin (motexafin gadolinium)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Status: COMPLETED